Cavernous Sinus Thrombosis Clinical Presentation
- Author: Rahul Sharma, MD, MBA, FACEP; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
The early signs and symptoms of cavernous sinus thrombosis (CST) may not be specific. A patient who presents with headache and any cranial nerve findings should be potentially evaluated for CST. The most common signs of CST are related to the anatomical structures affected within the cavernous sinus, as depicted in the image below.
Patients generally have sinusitis or a midface infection (most commonly a furuncle) for 5-10 days. In as many as 25% of cases in which a furuncle is the precipitant, it will have been manipulated in some fashion (eg, squeezing, surgical incision).
The clinical presentation is usually due to the venous obstruction as well as impairment of the cranial nerves that are near the cavernous sinus.
Headache is the most common presentation symptom and usually precedes fevers, periorbital edema, and cranial nerve signs. The headache is usually sharp, increases progressively, and is usually localized to the regions innervated by the ophthalmic and maxillary branches of the fifth cranial nerve.
In some patients, periorbital findings do not develop early on, and the clinical picture is subtle.
Some cases of CST may present with focal cranial nerve abnormalities possibly presenting similar to an ischemic stroke.
As the infection tracts posteriorly, patients complain of orbital pain and fullness accompanied by periorbital edema and visual disturbances.
Without effective therapy, signs appear in the contralateral eye by spreading through the communicating veins to the contralateral cavernous sinus. Eye swelling begins as a unilateral process and spreads to the other eye within 24-48 hours via the intercavernous sinuses. This is pathognomonic for CST.
The patient rapidly develops mental status changes including confusion, drowsiness, and coma from CNS involvement and/or sepsis. Death follows shortly thereafter.
Other than the findings associated with the primary infection, the following signs are typical for cavernous sinus thrombosis:
Periorbital edema may be the earliest physical finding.
Chemosis results from occlusion of the ophthalmic veins.
Lateral gaze palsy (isolated cranial nerve VI) is usually seen first since CN VI lies freely within the sinus in contrast to CN III and IV, which lie within the lateral walls of the sinus. 
Ptosis, mydriasis, and eye muscle weakness from cranial nerve III dysfunction
Manifestations of increased retrobulbar pressure follow.
Signs of increased intraocular pressure (IOP) may be observed.
Pupillary responses are sluggish.
Decreased visual acuity is common owing to increased IOP and traction on the optic nerve and central retinal artery.
Hypoesthesia or hyperesthesia in dermatomes supplied by the V1 and V2 branches of the fifth cranial nerve.
Appearance of signs and symptoms in the contralateral eye is diagnostic of CST, although the process may remain confined to one eye.
Meningeal signs, including nuchal rigidity and Kernig and Brudzinski signs, may be noted.
Systemic signs indicative of sepsis are late findings. They include chills, fever, shock, delirium, and coma.
Most cases of septic cavernous sinus thrombosis (CST) are due to an acute infection in an otherwise healthy individual. However, patients with chronic sinusitis or diabetes mellitus may be at a slightly higher risk.
The causative agent is generally Staphylococcus aureus, although streptococci, pneumococci, and fungi may be implicated in rare cases.
Laupland KB. Vascular and parameningeal infections of the head and neck. Infect Dis Clin North Am. 2007 Jun. 21(2):577-90, viii. [Medline].
Seow VK, Chong CF, Wang TL, Lin CM, Lin IY. Cavernous sinus thrombophlebitis masquerading as ischaemic stroke: a catastrophic pitfall in any emergency department. Emerg Med J. 2007 Jun. 24(6):440. [Medline].
Duong DK, Leo MM, Mitchell EL. Neuro-ophthalmology. Emerg Med Clin North Am. 2008 Feb. 26(1):137-80, vii. [Medline].
Misra UK, Kalita J, Bansal V. D-dimer is useful in the diagnosis of cortical venous sinus thrombosis. Neurol India. 2009 Jan-Feb. 57(1):50-4. [Medline].
Pendharkar HS, Gupta AK, Bodhey N, Nair M. Diffusion restriction in thrombosed superior ophthalmic veins: two cases of diverse etiology and literature review. J Radiol Case Rep. 2011. 5(3):8-16. [Medline]. [Full Text].
Korchi AM, Cuvincius V, Caetano J, Becker M, Lovblad KO, Vargas MI. Imaging of the cavernous sinus lesions. Diagn Interv Imaging. 2014. 95(9):849-859.
Andrews CM, Hawk HE, Holmstedt CA. Case Report: Septic cavernous sinus thrombosis. Neurol Clin Neurosci. 2014. 2:117-118.
Tang Y, Booth T, Steward M, Solbach T, Wilhelm T. The imaging of conditions affecting the cavernous sinus. Clin Radiol. 2010 Nov. 65(11):937-45. [Medline].
Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011 Aug 10. CD002005. [Medline].
Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Bousser MG, Stam J. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010 Nov. 41(11):2575-80. [Medline].
Naesens R, Ronsyn M, Druwé P, Denis O, Ieven M, Jeurissen A. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2009 Sep. 58:1247-51. [Medline].
Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol. 2002 Sep. 116(9):667-76. [Medline].
Canhao P, Ferro JM, Lindgren AG. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005 Aug. 36(8):1720-5. [Medline].
Cannon ML, Antonio BL, McCloskey JJ, et al. Cavernous sinus thrombosis complicating sinusitis. Pediatr Crit Care Med. 2004 Jan. 5(1):86-8. [Medline].
DiNubile MJ. Septic thrombosis of the cavernous sinuses. Arch Neurol. 1988 May. 45(5):567-72. [Medline].
Ferro JM, Canhao P, Bousser MG. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005 Sep. 36(9):1927-32. [Medline].
Goodwin WJ. Orbital complications of ethmoiditis. Otolaryngol Clin North Am. 1985 Feb. 18(1):139-47. [Medline].
Heckmann JG, Tomandl B. Cavernous sinus thrombosis. Lancet. 2003 Dec 13. 362(9400):1958. [Medline].
Karlin RJ, Robinson WA. Septic cavernous sinus thrombosis. Ann Emerg Med. 1984 Jun. 13(6):449-55. [Medline].
Lessner A, Stern GA. Preseptal and orbital cellulitis. Infect Dis Clin North Am. 1992 Dec. 6(4):933-52. [Medline].
Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988 Apr. 38(4):517-22. [Medline].
Peters KS. Secondary headache and head pain emergencies. Prim Care. 2004 Jun. 31(2):381-93, vii. [Medline].
Schnipper D, Spiegel JH. Management of intracranial complications of sinus surgery. Otolaryngol Clin North Am. 2004 Apr. 37(2):453-72, ix. [Medline].
Southwick FS, Richardson EP, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore). 1986 Mar. 65(2):82-106. [Medline].
Watkins LM, Pasternack MS, Banks M. Bilateral cavernous sinus thromboses and intraorbital abscesses secondary to Streptococcus milleri. Ophthalmology. 2003 Mar. 110(3):569-74. [Medline].
Yanofsky NN. The acute painful eye. Emerg Med Clin North Am. 1988 Feb. 6(1):21-42. [Medline].
Zimmer J, Bhatt J, et al. Is it all in his head?. The Internet Journal of Pediatrics and Neonatology. 2006. 6: